Siegel RL, Miller KD, Wagle NS and Jemal A, Cancer statistics. CA: A Cancer Journal for Clinicians. 2023;73:17–48. https://doi.org/10.3322/caac.21763.

Fuchs CS, Azevedo S, Okusaka T, Van Laethem JL, Lipton LR, Riess H et al. A phase 3 randomized, double-blind, placebo-controlled trial of ganitumab or placebo in combination with gemcitabine as first-line therapy for metastatic adenocarcinoma of the pancreas: the GAMMA trial. Ann Oncol 2015;26:921–927. https://doi.org/10.1093/annonc/mdv027.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xing H, Wang J, Wang Y, Tong M, Hu H, Huang C et al. Diagnostic value of CA 19–9 and carcinoembryonic antigen for pancreatic cancer: A meta-analysis. Gastroenterol Res Pract 2018;2018:8704751. https://doi.org/10.1155/2018/8704751.

Article  PubMed  PubMed Central  Google Scholar 

Deo RC. Machine learning in medicine. Circulation 2015;132:1920–1930.

PubMed  PubMed Central  Google Scholar 

Toh TS, Dondelinger F, Wang D. Looking beyond the hype: Applied AI and machine learning in translational medicine. EBioMedicine 2019;47:607–615. https://doi.org/10.1016/j.ebiom.2019.08.027.

Article  PubMed  PubMed Central  Google Scholar 

Möller A, Lobb RJ. The evolving translational potential of small extracellular vesicles in cancer. Nat Rev Cancer 2020;20:697–709. https://doi.org/10.1038/s41568-020-00299-w.

Article  CAS  PubMed  Google Scholar 

Wang M, Ji S, Shao G, Zhang J, Zhao K, Wang Z et al. Effect of exosome biomarkers for diagnosis and prognosis of breast cancer patients. Clin Transl Oncol 2018;20:906–911. https://doi.org/10.1007/s12094-017-1805-0.

Article  CAS  PubMed  Google Scholar 

Hu J, Sheng Y, Kwak KJ, Shi J, Yu B, Lee LJ. A signal-amplifiable biochip quantifies extracellular vesicle-associated RNAs for early cancer detection. Nat Commun 2017;8:1683. https://doi.org/10.1038/s41467-017-01942-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Han Y, Drobisch P, Krüger A, William D, Grützmann K, Böthig L et al. Plasma extracellular vesicle messenger RNA profiling identifies prognostic EV signature for non-invasive risk stratification for survival prediction of patients with pancreatic ductal adenocarcinoma. J Hematol Oncol 2023;16:7. https://doi.org/10.1186/s13045-023-01404-w.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kroell N, Chen X, Maghmoumi A, Koenig M, Feil A, Greiff K. Sensor-based particle mass prediction of lightweight packaging waste using machine learning algorithms. Waste Manag 2021;136:253–265. https://doi.org/10.1016/j.wasman.2021.10.017.

Article  PubMed  Google Scholar 

Mizrahi JD, Surana R, Valle JW, Shroff RT. Pancreatic cancer. The Lancet 2020;395:2008–2020.

CAS  Google Scholar 

Yee NS, Lengerich EJ, Schmitz KH, Maranki JL, Gusani NJ, Tchelebi L et al. Frontiers in gastrointestinal oncology: advances in multi-disciplinary patient care. Biomedicines. 2018;6. https://doi.org/10.3390/biomedicines6020064.

Liang DH, Hall C and Lucci A. Circulating tumor cells in breast cancer. Tumor Liquid Biopsies. 2020:127–145

Buscail E, Chauvet A, Quincy P, Degrandi O, Buscail C, Lamrissi I et al. CD63-GPC1-positive exosomes coupled with CA19-9 Offer good diagnostic potential for resectable pancreatic ductal adenocarcinoma. Transl Oncol 2019;12:1395–1403. https://doi.org/10.1016/j.tranon.2019.07.009.

Article  PubMed  PubMed Central  Google Scholar 

Yong E. Cancer biomarkers: written in blood. Nature 2014;511:524–526. https://doi.org/10.1038/511524a.

Article  CAS  PubMed  Google Scholar 

Bidard FC, Peeters DJ, Fehm T, Nolé F, Gisbert-Criado R, Mavroudis D et al. Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data. Lancet Oncol 2014;15:406–414. https://doi.org/10.1016/s1470-2045(14)70069-5.

Article  PubMed  Google Scholar 

Dawson SJ, Tsui DW, Murtaza M, Biggs H, Rueda OM, Chin SF et al. Analysis of circulating tumor DNA to monitor metastatic breast cancer. N Engl J Med 2013;368:1199–1209. https://doi.org/10.1056/NEJMoa1213261.

Article  CAS  PubMed  Google Scholar 

Molibeli KM, Hu R, Liu Y, Xiong D, Tang L. Potential clinical applications of exosomal circular RNAs: more than diagnosis. Front Mol Biosci 2021;8:769832. https://doi.org/10.3389/fmolb.2021.769832.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gurung S, Perocheau D, Touramanidou L, Baruteau J. The exosome journey: from biogenesis to uptake and intracellular signalling. Cell Commun Signal 2021;19:47. https://doi.org/10.1186/s12964-021-00730-1.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Wang Z, Ding J, Xiao Y, Xiao K, Su P, Dong Z et al. Serum extracellular vesicles with NSD1 and FBXO7 mRNA as novel biomarkers for gastric cancer. Clin Biochem 2023;120:110653. https://doi.org/10.1016/j.clinbiochem.2023.110653.

Article  CAS  PubMed  Google Scholar 

Kumar SR, Kimchi ET, Manjunath Y, Gajagowni S, Stuckel AJ, Kaifi JT. RNA cargos in extracellular vesicles derived from blood serum in pancreas associated conditions. Sci Rep 2020;10:2800. https://doi.org/10.1038/s41598-020-59523-0.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kitagawa T, Taniuchi K, Tsuboi M, Sakaguchi M, Kohsaki T, Okabayashi T et al. Circulating pancreatic cancer exosomal RNAs for detection of pancreatic cancer. Mol Oncol 2019;13:212–227. https://doi.org/10.1002/1878-0261.12398.

Article  CAS  PubMed  Google Scholar 

Yang Z, LaRiviere MJ, Ko J, Till JE, Christensen T, Yee SS et al. A Multianalyte panel consisting of extracellular vesicle miRNAs and mRNAs, cfDNA, and CA19-9 shows utility for diagnosis and staging of pancreatic ductal adenocarcinoma. Clin Cancer Res 2020;26:3248–3258. https://doi.org/10.1158/1078-0432.Ccr-19-3313.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shi HH, Liu HE, Luo XJ. Hypermethylation-mediated silencing of NDRG4 promotes pancreatic ductal adenocarcinoma by regulating mitochondrial function. BMB Rep 2020;53:658–663. https://doi.org/10.5483/BMBRep.2020.53.12.168.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dong X, Li C, Deng C, Liu J, Li D, Zhou T et al. Regulated secretion of mutant p53 negatively affects T lymphocytes in the tumor microenvironment. Oncogene 2024;43:92–105. https://doi.org/10.1038/s41388-023-02886-1.

Article  CAS  PubMed  Google Scholar 

Huang J, Zhou H, Tan C, Mo S, Liu T, Kuang Y. The overexpression of actin related protein 2/3 complex subunit 1B(ARPC1B) promotes the ovarian cancer progression via activation of the Wnt/β-catenin signaling pathway. Front Immunol 2023;14:1182677. https://doi.org/10.3389/fimmu.2023.1182677.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gamallat Y, Zaaluk H, Kish EK, Abdelsalam R, Liosis K, Ghosh S et al. ARPC1B is associated with lethal prostate cancer and its inhibition decreases cell invasion and migration in vitro. Int J Mol Sci 2022;23. https://doi.org/10.3390/ijms23031476.

Liao Y, Li M, Chen X, Jiang Y, Yin XM. Interaction of TBC1D9B with mammalian ATG8 homologues regulates autophagic flux. Sci Rep 2018;8:13496. https://doi.org/10.1038/s41598-018-32003-2.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Shen M, Wang H, Wei K, Zhang J, You C. Five common tumor biomarkers and CEA for diagnosing early gastric cancer: a protocol for a network meta-analysis of diagnostic test accuracy. Medicine (Baltimore) 2018;97:e0577. https://doi.org/10.1097/md.0000000000010577.

Article  CAS  PubMed  Google Scholar